Join Fagron’s Vice President of FSS Operations, Jason McGuire, and Global Innovation Project Manager, Hudson Polonini, at the United States Pharmacopeia's Headquarters in Rockville, MD for the Third Annual Compounding Implementation Workshop - February 7th and 8th! USP envisions a world in which all have access to high-quality, safe, and beneficial medicines and partners with experts in the compounding pharmaceutical industry to discuss strategies to enhance the quality of patient care. Fagron Sterile Services US, along with its global parent Company Fagron, Inc. is proud to join members of the USP Compounding Expert Committee.Visit Tradeshow Website
February 7, 2023
February 8, 2023
Fagron Sterile Services US (FSS), a top-tier DEA and FDA-Registered 503B Outsourcing Provider, produces a reliable supply of high-quality sterile medications with cGMP compliant operations for patient-focused healthcare facilities across North America. FSS' team employs expertise in legal and regulatory compliance, pharmaceutical manufacturing and repackaging, leveraging industry leading automation, advanced environmental monitoring and sophisticated in-house quality testing labs. Batches are validated to support Beyond Use Dating (BUD) and only released after successful sterility, particulate matter and potency testing are complete. FSS offers a broad product portfolio across Operating Room Anesthesia (OR Syringes & IV Bags), Ophthalmics, Pain Management, and other Specialty Presentations, while holding Integrated Delivery Network (IDN)agreements within all major GPOs.